Rating History for Kalvista Pharmaceuticals Inc (KALV) by Citizens
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/29/2026 | Jonathan Wolleben | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
19.24 (27.00) |
40.33% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||


